Point Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 53.8

Forward Citations = 352

Loading Chart...

5 inventors (with patents filed for the assignee):

Barbara P Wallner (13 out of 34 patents)

Glenn T Miller (7 out of 11 patents)

Sharlene Adams (3 out of 13 patents)

4. Barry Jones (3 out of 3 patents)

5. William Bachovchin (3 out of 3 patents)

13 patents: Sort by Forward Citations

1. 7282484 - Anti-tumor agents (2007-10-16),

2. 7276371 - Stimulation of hematopoietic cells in vitro (2007-10-02),

3. 7265118 - Regulation of substrate activity (2007-09-04),

4. 7259138 - Anti-tumor agents (2007-08-21),

5. 7067489 - Hematopoietic stimulation (2006-06-27),

6. 6979697 - Regulation of substrate activity (2005-12-27),

7. 6949514 - Anti-tumor agents (2005-09-27),

8. 6890904 - Anti-tumor agents (2005-05-10),

9. 6770628 - Hematopoietic stimulation (2004-08-03),

10. 6703238 - Methods for expanding antigen-specific T cells (2004-03-09),

11. 6355614 - Cyclic boroproline compounds (2002-03-12),

12. 6300314 - Hematopoietic stimulation (2001-10-09),

13. 6258597 - Stimulation of hematopoietic cells in vitro (2001-07-10),

Company Overview

Point Therapeutics, Inc. is a biotechnology company based in Boston, MA, focused on developing innovative therapies for patients with serious diseases. The company specializes in the research and development of novel drug candidates, particularly in the fields of oncology and rare diseases. By leveraging advanced scientific techniques and a commitment to addressing unmet medical needs, Point Therapeutics aims to deliver transformative treatment options that improve patient outcomes and enhance quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#157 in Boston, MA

#1,443 in Massachusetts

#23,863 in US

#45,104 in the World

Boston, MA, United States of America